$3.94 Earnings Per Share Expected for HCA Healthcare, Inc. (NYSE:HCA) This Quarter

Wall Street brokerages predict that HCA Healthcare, Inc. (NYSE:HCAGet Rating) will announce $3.94 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for HCA Healthcare’s earnings. The highest EPS estimate is $4.14 and the lowest is $3.62. HCA Healthcare reported earnings of $4.37 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 9.8%. The firm is expected to announce its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that HCA Healthcare will report full year earnings of $17.36 per share for the current financial year, with EPS estimates ranging from $16.90 to $19.05. For the next year, analysts anticipate that the firm will post earnings of $19.19 per share, with EPS estimates ranging from $18.18 to $20.80. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings results on Friday, April 22nd. The company reported $4.12 EPS for the quarter, missing analysts’ consensus estimates of $4.25 by ($0.13). The firm had revenue of $14.95 billion for the quarter, compared to analyst estimates of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter last year, the company earned $4.14 earnings per share.

Several equities analysts recently commented on the company. Cowen dropped their target price on HCA Healthcare from $265.00 to $241.00 in a report on Monday, April 25th. BMO Capital Markets dropped their target price on HCA Healthcare from $275.00 to $240.00 in a report on Tuesday, April 26th. Citigroup dropped their price objective on HCA Healthcare from $277.00 to $254.00 and set a “buy” rating on the stock in a report on Monday, April 25th. Credit Suisse Group dropped their price objective on HCA Healthcare from $296.00 to $260.00 and set an “outperform” rating on the stock in a report on Monday, April 25th. Finally, StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, April 25th. Six analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Buy” and an average target price of $261.38.

In related news, major shareholder Thomas F. Frist, Jr. acquired 89,100 shares of the stock in a transaction dated Monday, May 2nd. The stock was bought at an average cost of $211.93 per share, with a total value of $18,882,963.00. Following the purchase, the insider now directly owns 478,955 shares of the company’s stock, valued at $101,504,933.15. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Jennifer Berres sold 2,358 shares of the business’s stock in a transaction on Friday, May 13th. The shares were sold at an average price of $218.87, for a total transaction of $516,095.46. Following the sale, the senior vice president now directly owns 11,392 shares of the company’s stock, valued at $2,493,367.04. The disclosure for this sale can be found here. Over the last ninety days, insiders acquired 91,370 shares of company stock valued at $19,373,375 and sold 14,380 shares valued at $3,723,203. 1.50% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. Equitec Proprietary Markets LLC acquired a new position in HCA Healthcare in the 4th quarter worth $26,000. GoalVest Advisory LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at about $26,000. Amplius Wealth Advisors LLC bought a new position in HCA Healthcare in the 4th quarter worth about $27,000. Wolff Wiese Magana LLC grew its position in HCA Healthcare by 1,833.3% in the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock worth $29,000 after purchasing an additional 110 shares during the last quarter. Finally, PYA Waltman Capital LLC bought a new position in HCA Healthcare in the 4th quarter worth about $31,000. Institutional investors and hedge funds own 67.87% of the company’s stock.

Shares of NYSE HCA traded up $1.65 during mid-day trading on Friday, hitting $204.78. The company had a trading volume of 1,481,549 shares, compared to its average volume of 2,739,897. The company has a market capitalization of $60.51 billion, a PE ratio of 9.64, a price-to-earnings-growth ratio of 1.30 and a beta of 1.61. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24. HCA Healthcare has a 1-year low of $198.69 and a 1-year high of $279.02. The business’s 50-day simple moving average is $240.86 and its 200 day simple moving average is $244.51.

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be paid a $0.56 dividend. The ex-dividend date is Wednesday, June 15th. This represents a $2.24 annualized dividend and a yield of 1.09%. HCA Healthcare’s payout ratio is currently 10.54%.

HCA Healthcare announced that its board has approved a stock buyback program on Thursday, January 27th that permits the company to repurchase $8.00 billion in shares. This repurchase authorization permits the company to repurchase up to 10.9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.